<DOC>
	<DOCNO>NCT02267473</DOCNO>
	<brief_summary>Patients chronic Hepatitis B oral antiviral treatment least 6 month study start monitor yearly kidney function change within routine outpatient visit . Therefore urine sample collect additional blood test do within routine blood sampling .</brief_summary>
	<brief_title>Hepatitis B Patients Under Oral Nucleos ( ) Ide Treatment With Intermittent Assessment Kidney Function</brief_title>
	<detailed_description>This non-interventional , long-term observational cohort study evaluate demographic , clinical , biochemical virological parameter outpatient chronic Hepatitis B oral antiviral treatment approve Nucleos ( ) ide &gt; 6 month study inclusion . During routine outpatient visit annually assessment kidney function especially proximal tubular dysfunction perform comedication explore . Patients include study follow 5 year .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>chronic Hepatitis B Virus infection indication antiviral treatment due recent german Hepatitis B guideline oral intake approve Nucleos ( ) ide minimum 6 month inclusion ALT &lt; 2 x UNL ( upper normal limit ) study inclusion age 18 89 year sign informed consent form coinfection Hepatitis D Virus ( HDV ) , Hepatitis C Virus ( HCV ) Human Immunodeficiency Virus ( HIV ) Comorbidities hinder study performance ( e.g . malignancy , relevant psychiatric disorder ) hepatocellular carcinoma hepatic metastasis legally incapacitate patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>